No abstract available
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aged, 80 and over
-
Aniline Compounds / chemical synthesis
-
Aniline Compounds / pharmacology
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / pharmacology*
-
Biological Assay
-
Bridged Bicyclo Compounds, Heterocyclic / chemical synthesis
-
Bridged Bicyclo Compounds, Heterocyclic / pharmacology
-
Cell Line, Tumor
-
Cytochromes c / metabolism
-
Female
-
Gene Expression Regulation, Neoplastic*
-
Humans
-
Male
-
Middle Aged
-
Mitochondria / drug effects
-
Mitochondria / metabolism
-
Mitochondria / pathology
-
Multiple Myeloma / diagnosis*
-
Multiple Myeloma / genetics
-
Multiple Myeloma / metabolism
-
Multiple Myeloma / pathology
-
Myeloid Cell Leukemia Sequence 1 Protein / antagonists & inhibitors*
-
Myeloid Cell Leukemia Sequence 1 Protein / genetics
-
Myeloid Cell Leukemia Sequence 1 Protein / metabolism
-
Organ Specificity
-
Peptides / chemical synthesis
-
Peptides / pharmacology*
-
Plasma Cells / drug effects
-
Plasma Cells / metabolism
-
Plasma Cells / pathology
-
Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors*
-
Proto-Oncogene Proteins c-bcl-2 / genetics
-
Proto-Oncogene Proteins c-bcl-2 / metabolism
-
Recurrence
-
Sulfonamides / chemical synthesis
-
Sulfonamides / pharmacology
-
bcl-X Protein / antagonists & inhibitors*
-
bcl-X Protein / genetics
-
bcl-X Protein / metabolism
Substances
-
Aniline Compounds
-
Antineoplastic Agents
-
BCL2 protein, human
-
BCL2L1 protein, human
-
Bridged Bicyclo Compounds, Heterocyclic
-
MCL1 protein, human
-
Myeloid Cell Leukemia Sequence 1 Protein
-
Peptides
-
Proto-Oncogene Proteins c-bcl-2
-
Sulfonamides
-
bcl-X Protein
-
Cytochromes c
-
venetoclax
-
navitoclax